Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.
Gladstone scientists have discovered environmental factors that critically influence the growth of a new type of stem cell.
Gladstone scientists participate in an international consortium that uses stem cell technology to tackle Huntington's disease
Gladstone Institutes Senior Investigator Shinya Yamanaka, MD, PhD, has won the Millennium Technology Award Grand Prize, the world's largest and most prominent technology award.
Scientists at the Gladstone Institutes have transformed skin cells into cells that develop into a neural network.
Scientists at the Gladstone Institutes today are announcing a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks—by converting scar-forming cardiac cells into beating heart muscle.
The American Association for the Advancement of Science (AAAS) has named Gladstone Senior Investigator Deepak Srivastava, MD, a Fellow for his efforts to advance science and its applications.
The Gladstone Institutes and the Roddenberry Foundation today inaugurated the Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, a new unit founded on an unprecedented $5 million gift from the foundation that was established to honor the legacy of Star Trek creator Gene Roddenberry.
The California Academy of Sciences today will induct Gladstone Institutes Senior Investigator Bruce Conklin, MD, as an Academy Fellow, bestowing yet another honor on one of San Francisco's most esteemed cardiovascular scientists.
Scientists at the Gladstone Institutes have gained new insight into the delicate relationship between two proteins that, when out of balance, can prevent the normal development of stem cells in the heart and may also be important in some types of cancer.